|
    ADIL U.S.: Nasdaq

    ADial Pharmaceuticals Inc.

    ADILUS
    After Hours
    Back To Top
    Last Updated: Jul 30, 2021 6:01 p.m. EDT Delayed quote

    $ 2.4900

    0.05 2.05%
    After Hours Volume: 164
    Close Chg Chg %
    $2.4400 -0.0100 -0.41%
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 56.97K 65 Day Avg: 1.17M
    5% vs Avg
    2.3600 Day Range 2.4800
    1.1400 52 Week Range 4.0000

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ADIL Overview

    Performance

    5 Day
    • 2.09%
    1 Month
    • -17.01%
    3 Month
    • 10.91%
    YTD
    • 43.53%
    1 Year
    • 51.55%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 2 Full Ratings

    Recent News

    • eLesor
    • Dow Jones
    • Other News
    • Press Releases

    ADial Pharmaceuticals Inc.

    Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.